07:45 AM EDT, 09/03/2025 (MT Newswires) -- TG Therapeutics ( TGTX ) said Wednesday that its board approved a new share repurchase program of up to $100 million.

The new program follows the completion of the previous $100 million share buyback program, which was announced in 2024. Under this program, the company repurchased approximately 3.5 million common shares at an average price of $28.55 per share, as stated in a press release.